Related Experiment Video
Updated: Jun 28, 2026
11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.6K
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review
Curtis M Wojcik1, Meghan Beier2, Kathleen Costello3
1Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 23, 2019
Summary
Computerized neuropsychological assessment devices (CNADs) effectively screen for cognitive impairment in multiple sclerosis (MS). Several CNADs demonstrate strong psychometric properties for MS assessment.
Area of Science:
- Neuroscience
- Psychology
- Medical Technology
Background:
- Computerized neuropsychological assessment devices (CNADs) are increasingly used for cognitive impairment.
- Previous reviews of CNADs for multiple sclerosis (MS) lacked rigorous psychometric comparisons.
Purpose of the Study:
- Systematically review the literature on CNAD use in MS.
- Identify reliable and valid computerized tests for MS cognitive assessment.
Main Methods:
- Searched four major databases for computerized testing and MS publications.
- Recorded psychometric properties (reliability, validity) and administration details for CNADs.
Main Results:
- Identified 11 batteries and 33 individual tests from 120 articles.
- CogState Brief Battery, CDR Battery, NeuroTrax, CNS-Vital Signs, and computer-based SDMT showed strong psychometric support.
Conclusions:
- Several CNADs are valid for screening MS-related cognitive impairment.
- CNADs can supplement conventional neuropsychological assessments.
- The need for technicians and controlled environments for CNAD testing in MS is uncertain.
